Comparative Study
doi: 10.1002/mds.20896.
End of day dyskinesia in advanced Parkinson's disease can be eliminated by bilateral subthalamic nucleus or globus pallidus deep brain stimulation
Affiliations
- PMID: 16637040
- DOI: 10.1002/mds.20896
Item in Clipboard
Comparative Study
End of day dyskinesia in advanced Parkinson's disease can be eliminated by bilateral subthalamic nucleus or globus pallidus deep brain stimulation
Mov Disord.
2006 Aug.
Abstract
We report the therapeutic effects of deep brain stimulation (DBS) in 2 patients with Parkinson's disease (PD) with severe end of dose dyskinesia that was resistant to medical therapy. In both patients, severe, end of day ballistic dyskinesias occurred when the last levodopa dose of the day was wearing off. Globus pallidus (GPi) DBS in 1 case and subthalamic (STN) DBS in the second case produced full resolution of end of day dyskinesia.
(c) 2006 Movement Disorder Society
Similar articles
-
Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.Arch Neurol. 2005 Apr;62(4):554-60. doi: 10.1001/archneur.62.4.554. Arch Neurol. 2005. PMID: 15824252 Clinical Trial.
-
Globus pallidus stimulation in advanced Parkinson's disease.J Clin Neurosci. 2007 Mar;14(3):208-15. doi: 10.1016/j.jocn.2005.11.023. Epub 2006 Dec 5. J Clin Neurosci. 2007. PMID: 17150360 Clinical Trial.
-
GPi and STN deep brain stimulation can suppress dyskinesia in Parkinson's disease.Parkinsonism Relat Disord. 2012 Aug;18(7):814-8. doi: 10.1016/j.parkreldis.2012.03.022. Epub 2012 Apr 21. Parkinsonism Relat Disord. 2012. PMID: 22525365
-
State of the art: deep brain stimulation in Parkinson's disease.J Med Assoc Thai. 2006 Mar;89(3):390-400. J Med Assoc Thai. 2006. PMID: 16696426 Review.
-
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation for the Treatment of Patients With Parkinson's Disease: Executive Summary.Neurosurgery. 2018 Jun 1;82(6):753-756. doi: 10.1093/neuros/nyy037. Neurosurgery. 2018. PMID: 29538685 Free PMC article.
Cited by
-
Drug-induced dyskinesia in Parkinson's disease. Should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia?BMC Med. 2013 Mar 20;11:76. doi: 10.1186/1741-7015-11-76. BMC Med. 2013. PMID: 23514355 Free PMC article. Review.
-
Characterizing Deep Brain Stimulation effects in computationally efficient neural network models.Nonlinear Biomed Phys. 2011 Apr 15;5(1):2. doi: 10.1186/1753-4631-5-2. Nonlinear Biomed Phys. 2011. PMID: 21496222 Free PMC article.
-
A video-atlas of levodopa-induced dyskinesia in Parkinson's disease: terminology matters.Neurol Sci. 2024 Apr;45(4):1389-1397. doi: 10.1007/s10072-023-07209-6. Epub 2023 Nov 21. Neurol Sci. 2024. PMID: 37987930 Review.
-
The role of the subthalamic nucleus in L-DOPA induced dyskinesia in 6-hydroxydopamine lesioned rats.PLoS One. 2012;7(8):e42652. doi: 10.1371/journal.pone.0042652. Epub 2012 Aug 6. PLoS One. 2012. PMID: 22880070 Free PMC article.
-
Circuit Mechanisms of L-DOPA-Induced Dyskinesia (LID).Front Neurosci. 2021 Mar 10;15:614412. doi: 10.3389/fnins.2021.614412. eCollection 2021. Front Neurosci. 2021. PMID: 33776634 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
